Cerebrospinal fluid neuropeptides and monoaminergic transmitters in patients with trigeminal neuralgia

Headache

Volumn 37, Issue 4, 1997, Pages 211-216

  Strittmatter, Matthias ^a   Grauer, Markus ^a   Isenberg, Elke ^a   Hamann, Gerhard ^a   Fischer, Christian ^a   Hoffmann, Karl Heinz ^a   Blaes, Franz ^a   Schimrigk, Klaus ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

CSF; neuropeptides; pain; substance P; transmitters; trigeminal neuralgia

Indexed keywords

ADRENALIN; HOMOVANILLIC ACID; NEUROPEPTIDE; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN; SOMATOSTATIN; SUBSTANCE P; VANILMANDELIC ACID;

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PAIN ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; TRIGEMINUS NEURALGIA;

BIOGENIC MONOAMINES; EPINEPHRINE; FEMALE; HOMOVANILLIC ACID; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; MIDDLE AGED; NEUROPEPTIDES; NOREPINEPHRINE; SOMATOSTATIN; SUBSTANCE P; TRIGEMINAL NEURALGIA; VANILMANDELIC ACID;

EID: 0030987440     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.1997.3704211.x     Document Type: Article

References (37)

1. Urculo E, Martinez L, Arrazola M, Ramirez R. Macroscopic effects of percutaneous trigeminal ganglion compression (Mullan's technique): an anatomic study. Neurosurgery. 1995;36:776-779.
2. Hamlyn PJ, King TT. Neurovascular compression in trigeminal neuralgia: a clinical and anatomical study. J Neurosurg. 1992;76:948-954.
3. Mendoza N, Illingworth RD. Trigeminal neuralgia treated by microvascular decompression: a long-term follow-up study. Br J Neurosurg. 1995;9:13-19.
4. Sidebottom A, Maxwell S. The medical and surgical management of trigeminal neuralgia. J Clin Pharm Ther. 1995;20:31-35.
5. Umehara F, Kamishima K, Kashio N, Yamaguchi K, Sakimoto T, Osame M. Magnetic resonance tomographic angiography: diagnostic value in trigeminal neuralgia. Neuroradiology. 1995;37:353-355.
6. Calvin WH, Loeser JD, Howe JF. A neurophysiological theory for the pain mechanism of tic douloreux. Pain. 1977;3:147-154.
7. Loeser JD. Tic douloureux and atypical face pain. In: Wall DW, Melzack R, eds. Textbook of Pain. New York: Churchill Livingstone; 1994:699-710.
8. Goadsby PJ, Edvinsson L. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain. 1994;117:427-434.
9. Goadsby PJ, Edvinsson L, Ekman R. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system, Ann Neurol. 1988;23:193-196.
10. Coderre TJ, Katz J, Vaccarino AL, Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain. 1993;52:259-285.
11. Kwiat GC, Basbaum AI. The origin of brainstem noradrenergic and serotonergic projections to the spinal cord dorsal horn in the rat. Somatosens Mot Res. 1992;9:157-173.
12. Bennett GJ. Animal models of neuropathic pain. In: Gebhardt GF, Hammond DL, Jensen DS, eds. Proceedings of the 7th World Congress on Pain. Progress in Pain Research and Management. II. Seattle: IASP Press; 1994:495-510.
13. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):10-73.
14. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain. 1975;1:277-299.
15. Melzack R. The short-form McGill Questionnaire. Pain. 1987;30:191-197.
16. Stein C, Mendl G. The German counterpart to McGill Pain Questionnaire. Pain. 1988;32:251-255.
17. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
18. Strittmatter M, Hamann G, Grauer M, et al. Altered activity of the sympathetic nervous system activity and changes in the balance of hypophyseal, pituitary and adrenal hormones in patients with cluster headache. Neuroreport. 1996;7:1229-1234.
19. Bouckoms AJ, Poletti CH, Sweet WH, Carr D, Keith D. Trigeminal facial pain: a model of peptides and monoamines in intracerebral cerebrospinal fluid. Agressologie. 1991;32:271-274.
20. Bouckoms AJ, Sweet WH, Poletti C, et al. Monoamines in the brain cerebrospinal fluid of facial pain patients. Anesth Prog. 1992;39:201-208.
21. Moskowitz MA. Basic mechanisms in vascular headache. Neurol Clin. 1990;8:801-815.
22. Rang HP, Bevan S, Dray A. Chemical activation of nociceptive peripheral neurones. Br Med Bull. 1991;47:534-548.
23. Pedersen-Bjergaard U, Nielsen LB, Jensen K, Edvinsson L, Jansen I, Olesen J. Algesia and local responses induced by neurokinin A and substance P in human skin and temporal muscle. Peptides. 1989;10:1147-1152.
24. Edvinsson L, Goadsby PJ. Neuropeptides in migraine and cluster headache. Cephalalgia. 1994;14:320-327.
25. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol. 1993;33:48-56.
26. Brodin E, Gazelius JB, Lundberg JM, Olgart L. Substance P in trigeminal nerve endings: occurrence and release. Acta Physiol Scand. 1981;111:501-503.
27. Gazelius B, Brodin E, Olgart L, Panopoulos P. Evidence that substance P is a mediator of antidromic vasodilatation using somatostatin as a release inhibitor. Acta Physiol Scand. 1981;113:155-159.
28. Dray A, Urban L, Dickenson A. Pharmacology of chronic pain. Trends Pharmacol Sci. 1994;15:190-197.
29. Asberg M, Thoren P, Traskman L, Bertilsson L, Ringberger V. "Serotonin depression" - a biochemical subgroup within the affective disorders? Science. 1976;191:478-480.
30. Jensen K, Tuxen C, Pedersen-Bjergaard U, Jansen I. Pain, tenderness, wheal and flare induced by substance-P, bradykinin and 5-hydroxytryptamine in humans. Cephalalgia. 1991;11:175-182.
31. Myers RD. Neuroactive peptides: unique phases in research on mammalian brain over three decades. Peptides. 1995;15:367-381.
32. Rosen A, Franck J, Brodin E. Effects of acute systemic treatment with 5 HT-uptake blocker alaproclate on tissue levels and release of substance P in rat periaqueductal grey. Neuropeptides. 1995;28:317-324.
33. Uddman R, Edvinsson L, Jansen I, et al. Peptide-containing nerve fibres in human extracranial tissue: a morphological basis for neuropeptide involvement in extracranial pain? Pain. 1986;27:391-399.
34. Almay BG, Haggendal J, von Knorring L, Oreland L. 5-HIAA and HVA in CSF in patients with idiopathic pain disorders. Biol Psychiatry. 1987;22:403-412.
35. Lechin F, van der Dijs B, Lechin ME, et al. Pimozide therapy for trigeminal neuralgia. Arch Neurol. 1989;46:960-963.
36. France RD, Urban BJ, Pelton S, Kilts CD, Hong JS, Nemeroff CB. CSF monoamine metabolites in chronic pain. Pain. 1987;31:189-198.
37. Glover V, Jarman J, Sandler M. Migraine and depression: biological aspects. J Psychiat Res. 1993;27:223-231.